Kyntra Bio, Inc. · NASDAQ:KYNB

Armistice Capital, LLC reported a 9.89% stake in Kyntra Bio, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Armistice Capital, LLC reported a 9.89% stake in Kyntra Bio, Inc., 400,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.89%
Shares
400,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.89%400,000
Steven Boyd9.89%400,000

Source

View original at SEC

Related